cjc-1295 ipamorelin clinical trials safety CJC-1295 + Ipamorelin ipamorelin clinical trial growth hormone – ipamorelin safety study CJC‑1295 &

The Science: GHK-Cu as a "Biological Architect" GHK-Cu (Copper Tripeptide-1) is a naturally occurring complex in human plasma that declines sharply as we age

For GHK-Cu wound healing, this means explicitly communicating: GHK-Cu is not FDA-approved as a drug for any indication Human wound-healing evidence is limited to small, non-randomized studies The compounding pharmacy source is not subject to the same oversight as FDA-approved manufacturers Alternative, evidence-based wound-healing options exist (negative pressure wound therapy, growth factor therapies like becaplermin, advanced wound dressings) Monitoring will be required, with associated lab costs Document this conversation in the medical record

20 21 These mechanisms are why researchers are now exploring GLP-1s for broader roles in metabolic optimization, brain health, and longevity

Critical Quality Attributes (CQAs): The target particle size for optimal absorption must stay between 80nm and 200nm to ensure the vesicles move through the gut wall effectively